Cancer cachexia: a nutritional or a systemic inflammatory syndrome?

Josh McGovern, Ross D Dolan, Richard J Skipworth, Barry J Laird, Donald C McMillan

Journal: British journal of cancer 2022;127(3):379-382

PMID: 35523879

Abstract

Cancer cachexia has long been perceived as a nutritional syndrome. However, nutritional interventions have continued to be ineffective. With the recent recognition of the importance of systemic inflammation in the definition of this syndrome and treatment, has the time come to consider whether this syndrome is primarily a manifestation of systemic inflammation with the consequent implications for future treatment?

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Address: Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK. [email protected].; Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.; Institute of Cancer, University of Edinburgh, Edinburgh, UK.; St Columba's Hospice, Edinburgh, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.